Tuesday, April 23, 2024 9:48:25 AM
Recent VOR News
- Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:01:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:15:18 PM
- Vor Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:01:00 PM
- Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors • GlobeNewswire Inc. • 05/02/2024 08:01:00 PM
- Vor Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update • GlobeNewswire Inc. • 03/20/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:15:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:15:46 PM
- Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Vor Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:08:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 10:06:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 10:05:14 PM
- Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 12:36:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 12:34:33 AM
- Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update • GlobeNewswire Inc. • 01/17/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:03:56 PM
- Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/21/2023 09:01:00 PM
- Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/01/2023 09:01:00 PM
- Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit • GlobeNewswire Inc. • 11/27/2023 01:00:00 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM